{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:02:08Z","timestamp":1773050528183,"version":"3.50.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>Breslow thickness (BT) is the cornerstone of malignant melanoma staging. However, to our knowledge no-one has ever assessed the horizontal width of invasion, measured microscopically, as a prognostic feature. This was investigated as a prognostic feature in this study. A retrospective cohort of 1329 melanoma cases was collected from patients presenting to a UK teaching hospital from January 1, 2004, to December 31, 2014. The main outcome was overall survival (OS). We found that width was associated with OS in multivariable analysis (hazard ratio=1.05, 95% confidence interval: 1.03-1.07, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) and was similarly significant for melanoma-specific survival and metastasis-free survival. Its presence rendered BT nonsignificant. The width was significantly associated with OS after adjustment for American Joint Committee on Cancer (AJCC), version 8 clinical tumor stage (hazard ratio=1.05, 95% confidence interval: 1.03-1.07, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), and bootstrap validation showed only slight model optimism. Similar associations were seen for melanoma-specific survival and metastasis-free survival. However, the combination of invasive width and BT did not account for the outcome as well as another novel histologic feature, tumor area, which was measured using the calculated tumor area method. In conclusion, this study is the first investigation of a novel histologic feature, invasive melanoma width, and demonstrates its strong independent association with outcome.<\/jats:p>","DOI":"10.1097\/pas.0000000000001529","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T13:03:01Z","timestamp":1593522181000},"page":"1522-1527","source":"Crossref","is-referenced-by-count":7,"title":["The Width of Invasion in Malignant Melanoma Is a Novel Prognostic Feature That Accounts for Outcome Better Than Breslow Thickness"],"prefix":"10.1097","volume":"44","author":[{"given":"Gerald","family":"Saldanha","sequence":"first","affiliation":[{"name":"Leicester Cancer Research Centre"},{"name":"University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarushi","family":"Khanna","sequence":"additional","affiliation":[{"name":"Leicester Medical School, University of Leicester"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"O\u2019Riordan","sequence":"additional","affiliation":[{"name":"University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Bamford","sequence":"additional","affiliation":[{"name":"University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.5301\/tj.5000369","article-title":"Thickness and diameter in melanoma: is there a relation?","volume":"102","author":"Crocetti","year":"2016","journal-title":"Tumori"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/CMR.0000000000000184","article-title":"Association between tumor size and Breslow\u2019s thickness in malignant melanoma: a cross-sectional, multicenter study","volume":"25","author":"Moreno-Ramirez","year":"2015","journal-title":"Melanoma Res"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jaad.2018.09.034","article-title":"Prognostic value of the Breslow:diameter ratio in cutaneous melanoma","volume":"80","author":"Pinero-Madrona","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamadermatol.2019.0621","article-title":"Development and initial validation of calculated tumor area as a prognostic tool in cutaneous malignant melanoma","volume":"155","author":"Saldanha","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R14-20230922","first-page":"411","article-title":"What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models","volume":"66","author":"Babyak","year":"2004","journal-title":"Psychosom Med"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jclinepi.2015.04.005","article-title":"Prediction models need appropriate internal, internal-external, and external validation","volume":"69","author":"Steyerberg","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2307\/271063","article-title":"Bayesian model selection in social research","volume":"25","author":"Raftery","year":"1995","journal-title":"Sociol Methodol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1535-7163.MCT-10-0901","article-title":"Melanoma prognosis: a REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies","volume":"10","author":"Schramm","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000356121","article-title":"Tumor volume as a prognostic factor in resectable malignant melanoma","volume":"228","author":"Voss","year":"2014","journal-title":"Dermatology"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"Clark","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0046-8177(84)80310-X","article-title":"A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma","volume":"15","author":"Clark","year":"1984","journal-title":"Hum Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:55:42Z","timestamp":1695423342000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001529","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,26]]}}}